|MM is an incurable blood cancer |
characterised by multifocal tumour
deposits throughout the bone marrow.
Patient image provided by Prof Andrew
See the CCS blog feature on the research for more detail, "New blood test potential game-changer for myeloma patients" (2 June 2017)
“We’re still in the developmental phase but the concept has been proven,” Professor Spencer said. “We’ve demonstrated that you can detect more mutations and track what’s happening to them, you can measure them and follow them sequentially – which would be impossible in bone marrow biopsies,” he said.
Mithraprabhu S, Khong T, Ramachandran M et al. Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma. Leukemia. 2017;31:1695-705.